140 related articles for article (PubMed ID: 7512041)
1. Suppression of angiogenesis by the antitumor agent titanocene dichloride.
Bastaki M; Missirlis E; Klouras N; Karakiulakis G; Maragoudakis ME
Eur J Pharmacol; 1994 Jan; 251(2-3):263-9. PubMed ID: 7512041
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis by anthracyclines and titanocene dichloride.
Maragoudakis ME; Peristeris P; Missirlis E; Aletras A; Andriopoulou P; Haralabopoulos G
Ann N Y Acad Sci; 1994 Sep; 732():280-93. PubMed ID: 7526759
[TBL] [Abstract][Full Text] [Related]
3. Basement membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumor properties.
Maragoudakis ME; Missirlis E; Karakiulakis GD; Sarmonica M; Bastakis M; Tsopanoglou N
Kidney Int; 1993 Jan; 43(1):147-50. PubMed ID: 7679456
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
Köpf-Maier P
Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system.
Maragoudakis ME; Sarmonika M; Panoutsacopoulou M
J Pharmacol Exp Ther; 1989 Nov; 251(2):679-82. PubMed ID: 2478695
[TBL] [Abstract][Full Text] [Related]
6. A novel disintegrin salmosin inhibits tumor angiogenesis.
Kang IC; Lee YD; Kim DS
Cancer Res; 1999 Aug; 59(15):3754-60. PubMed ID: 10446992
[TBL] [Abstract][Full Text] [Related]
7. [Demonstration of the vasoproliferative activity of heparin on chorioallantoic membrane].
Ribatti D; Nico B; Roncali L
Boll Soc Ital Biol Sper; 1985 Sep; 61(9):1287-93. PubMed ID: 2416328
[No Abstract] [Full Text] [Related]
8. Basement membrane biosynthesis as a target to tumor therapy.
Maragoudakis ME; Missirlis E; Sarmonika M; Panoutsacopoulou M; Karakiulakis G
J Pharmacol Exp Ther; 1990 Feb; 252(2):753-7. PubMed ID: 1690295
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative activity and mechanism of action of titanocene dichloride.
Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
[TBL] [Abstract][Full Text] [Related]
10. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.
Presta M; Rusnati M; Belleri M; Morbidelli L; Ziche M; Ribatti D
Cancer Res; 1999 May; 59(10):2417-24. PubMed ID: 10344752
[TBL] [Abstract][Full Text] [Related]
11. Angiostatic activity of anticancer agents in the chick embryo chorioallantoic membrane (CHE-CAM) assay.
Steiner R
EXS; 1992; 61():449-54. PubMed ID: 1377570
[TBL] [Abstract][Full Text] [Related]
12. Rate of basement membrane biosynthesis as an index to angiogenesis.
Maragoudakis ME; Panoutsacopoulou M; Sarmonika M
Tissue Cell; 1988; 20(4):531-9. PubMed ID: 2467405
[TBL] [Abstract][Full Text] [Related]
13. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
14. Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo.
Nguyen NM; Lehr JE; Pienta KJ
Anticancer Res; 1993; 13(6A):2143-7. PubMed ID: 7507655
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3.
Anand-Apte B; Pepper MS; Voest E; Montesano R; Olsen B; Murphy G; Apte SS; Zetter B
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):817-23. PubMed ID: 9112976
[TBL] [Abstract][Full Text] [Related]
16. Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.
Liu N; Lapcevich RK; Underhill CB; Han Z; Gao F; Swartz G; Plum SM; Zhang L; Green SJ
Cancer Res; 2001 Feb; 61(3):1022-8. PubMed ID: 11221828
[TBL] [Abstract][Full Text] [Related]
17. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
Clapp C; Martial JA; Guzman RC; Rentier-Delure F; Weiner RI
Endocrinology; 1993 Sep; 133(3):1292-9. PubMed ID: 7689950
[TBL] [Abstract][Full Text] [Related]
18. The preclinical evaluation of angiogenesis inhibitors.
O'Reilly MS
Invest New Drugs; 1997; 15(1):5-13. PubMed ID: 9195285
[TBL] [Abstract][Full Text] [Related]
19. Involvement of nitric oxide in the inhibition of angiogenesis by interleukin-2.
Sakkoula E; Pipili-Synetos E; Maragoudakis ME
Br J Pharmacol; 1997 Nov; 122(5):793-5. PubMed ID: 9384490
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenesis by humulone, a bitter acid from beer hop.
Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S
Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
